Question 1

Who are the top researchers at Probiodrug (Germany)?

Accepted Answer

Ranked on the quality score, Stephan Schilling, Hans‐Ulrich Demuth and Martin Kleinschmidt lead among researchers whose main affiliation is Probiodrug (Germany).

Question 2

What are the most cited papers from Probiodrug (Germany)?

Accepted Answer

The most cited paper from Probiodrug (Germany) is "Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β" (Justin M. Nussbaum, Stephan Schilling, Holger Cynis et al., 2012), with 437 citations. Next come "Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology" (357) and "Dipeptidyl Peptidase IV Inhibitor Treatment Stimulates β-Cell Survival and Islet Neogenesis in Streptozotocin-Induced Diabetic Rats" (334).

Question 3

Which research topics does Probiodrug (Germany) publish most on?

Accepted Answer

By volume in 2022-now: CRISPR and Genetic Engineering, Retinal Development and Disorders and Retinal Diseases and Treatments.

Question 4

Which keywords describe research at Probiodrug (Germany)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Oxidative Stress, Angiogenesis, Cancer, Tumor Microenvironment, Cancer Therapy, Immunosuppression, PET Imaging and Fibroblast Activation Protein.

Question 5

Which fields of science does Probiodrug (Germany) work in?

Accepted Answer

In all years, 54% of research at Probiodrug (Germany) is in Life Sciences, 37% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (37%), Medicine (36%), Neuroscience (14%). It does 3.2× the world's share of Life Sciences.

Question 6

Is Probiodrug (Germany)'s research output growing?

Accepted Answer

Output in 2022-2025 was 88% lower than in 2018-2021.